Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360256 · ClinicalTrials.gov registry record
Genetic Study of Liver Enzymes in Patients With Side Effects From Antidepressants
A clinical trial, sponsored by Augusta University.
- Completed
- Registry status
- 46
- Enrollment target
NCT00360256 is a clinical trial that has completed, run by Augusta University. The registered enrollment target is 46 participants.
The verdict
NCT00360256 has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The objective of this pilot study is to determine the genetic polymorphism rate of CYP450 2D6 and 2C19 metabolic enzymes in patients with significant adverse effects from antidepressants, compared to a population of patients who had no significant adverse effects from antidepressants metabolized by CYP2D6 and 2C19. The hypothesis for the proposed research is that the rate of 2D6 and 2C19 alleles that are associated with poor metabolizer status in the treatment-intolerant population will far exceed the rate found in patient population who takes antidepressants without adverse effects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00360256
The ClinicalTrials.gov registry entry for NCT00360256 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00360256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00360256 about?
NCT00360256 is a clinical study titled "Genetic Study of Liver Enzymes in Patients With Side Effects From Antidepressants". The objective of this pilot study is to determine the genetic polymorphism rate of CYP450 2D6 and 2C19 metabolic enzymes in patients with significant adverse effects from antidepressants, compared to a population of patients who had no significant adverse effects from antidepressants metabolized by ...
What is the current status of trial NCT00360256?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2006-06. Estimated completion is 2007-12.
Who is sponsoring clinical trial NCT00360256?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.